Skip to main content

Health

Minority Serving Institutions Partnership Planning Grants

It is well documented that the United States is becoming an increasingly racially and ethnically diverse country. By 2050 there will be no ethnic majority in the United States (U.S.). There is a need to ensure that the disability community keeps pace with and is responsive to the rapidly changing demographics of the country and the UCEDDs should play a critical role in such an effort. The DD Act recognizes the important role that UCEDDs play in enhancing the diversity of the workforce, requiring that UCEDDs enhance efforts to recruit and retain underrepresented groups at all levels in order to respond to the needs of nation and burgeoning diverse communities. It is essential now more than ever to ensure that UCEDDs are well positioned to address the unprecedented growth of diverse communities, including the growth in the number of people with disabilities, to ensure the future yields prosperity for all. To this end, UCEDDs need to know how to align their training programs and overall UCEDD organizational framework to truly reflect and respond to our nation's rich diversity. 

Application Due : Sep 01, 2018

University Centers of Excellence in Developmental Disabilities Diversity Fellowships

The Developmental Disabilities Assistance and Bill of Act (DD Act), requires that the programs authorized under the law are culturally competent to ensure that individuals with developmental disabilities, regardless of background, are full participants in all aspects of community life. According to the DD Act, Sec. 101. [42 USC 15001] c Policy. “It is the policy of the United States that all programs receiving assistance under this title shall be carried out in a manner consistent with the principles that Services, supports, and other assistance should be provided that demonstrate respect for personal preferences, and cultural differences; Specific efforts must be made to ensure that individuals with developmental disabilities from racial and ethnic minority backgrounds and their families enjoy increased and meaningful opportunities to access and use community services, individualized supports available to other individuals with developmental disabilities and their families; Recruitment efforts in disciplines related to developmental disabilities in pre-service training, community training, practice, administration, and Policymaking must focus on bringing larger numbers of racial and ethnic minorities into the disciplines in order to provide appropriate skills, knowledge, role models, and sufficient personnel to address the growing needs of an increasingly diverse population.

Application Due : Aug 01, 2020

Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional)

Partnerships to Advance Cancer Health Equity (CPACHE) Program. The CPACHE Program develops and maintains comprehensive, long-term, and mutually beneficial partnerships between institutions serving underserved health disparity population and underrepresented students (ISUPSs) and NCI-designated Cancer Centers (CCs). The program aims to achieve a stronger national cancer program and address challenges in cancer and cancer disparities research, education and outreach, as well as their impact on underserved populations. The institutions in each partnership are expected to work collaboratively to: 1) increase the cancer research and cancer research education capacity of the ISUPSs; 2) increase the number of students and investigators from underrepresented populations engaged in cancer research; 3) improve the effectiveness of CCs in developing and sustaining research programs focused on cancer health disparities and increase the number of investigators and students conducting cancer health disparities research; and 4) develop and implement cancer-related activities that benefit the surrounding underserved communities.

Application Due : Jan 09, 2020

Minority Fellowship Program (Short Title: MFP)

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT) is accepting applications for the fiscal year (FY) 2018 Minority Fellowship Program (Short Title:  MFP).  The purpose of this program is to reduce behavioral health disparities and improve healthcare outcomes for racial and ethnic minority populations by:  (1) increasing the knowledge of behavioral health professionals on issues related to treatment and recovery support for individuals who are from racial and ethnic minority populations and have a substance use disorder (SUD); (2) improving the quality of SUD treatment services delivered to racial and ethnic minority populations; and (3) increasing the number of culturally competent professionals in psychology focusing on services appropriate for those with SUDs, addiction psychiatry, and addiction medicine who teach, administer services, conduct research, and provide direct SUD services to racial and ethnic minority populations.

Application Due : July 25, 2018

NIH Director's Pioneer Award (DP1 - Clinical Trial Optional)

The NIH Directors Pioneer Award supports individual scientists of exceptional creativity who propose highly innovative and potentially transformative approaches to major challenges in the biomedical or behavioral sciences towards the goal of enhancing human health. Applications from individuals with diverse backgrounds and in any topic relevant to the broad mission of NIH are welcome. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigators research program or elsewhere. The NIH Directors Pioneer Award is a component of the High-Risk, High-Reward Research program of the NIH Common Fund.

Application Due : Sep 14, 2018

BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed)

This FOA solicits applications for research projects that use innovative, methodologically-integrated approaches to understand how circuit activity gives rise to mental experience and behavior. The goal is to support projects that can realize a meaningful outcome within 5 years. Applications should address circuit function in the context of specific neural systems such as sensation, perception, attention, reasoning, intention, decision-making, emotion, navigation, communication or homeostasis. Projects should link theory and data analysis to experimental design and should produce predictive models as deliverables. Projects should aim to improve the understanding of circuits of the central nervous system by systematically controlling stimuli and/or behavior while actively recording and/or manipulating dynamic patterns of neural activity. Projects can use non-human and human species, and applications should explain how the selected species offers ideal conditions for revealing general principles about the circuit basis of a specific behavior.

Application Due : June 25, 2018

Health Promotion and Disease Prevention Research Centers

This Notice of Funding Opportunity (NOFO) will provide funding to academic research centers to participate in the network of Health Promotion and Disease Prevention Research Centers (PRC Network) to: Establish and maintain a multi-disciplinary prevention research center (Center) that conducts high-quality applied health promotion and disease prevention research; Conduct one (1) applied public health prevention project (Core Research Project) using a community engagement approach to address a major cause of disease, disability, injury, or death in a population experiencing health disparities; Disseminate research findings to community, practice, and academic audiences; Translate evidence-based interventions for sustainability and widespread scale-up; and Serve as a resource, as part of the PRC Network, for developing, implementing, evaluating, disseminating, and translating evidence-based public health interventions at local, state, tribal, or national levels.

Application Due : Nov 10, 2020

Promoting, Strengthening and Enhancing Disease Prevention by Collaboration with Targeted Stakeholders

The purpose of this NOFO is to provide support for:Communication and education activities to promote and maintain accurate information about vaccines among stakeholders and the general publicEducation of USDA/WIC staff about the latest vaccine recommendations and vaccine access points to facilitate vaccination referrals to WIC participants.

Application Due : June 11, 2018

Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages applications for Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research. The institute seeks teams of researchers working at different levels of analysis and employing integrative, novel, and creative experimental approaches to address high-risk, high-impact questions in basic neuroscience research, or in translational research with the primary objectives of: (a) advancing the state of the science in basic brain and behavior research that will uncover and dissect the underlying mechanisms that will ultimately provide the foundation for understanding mental disorders; (b) supporting the integration and translation of basic and clinical neuroscience research on severe mental illnesses; and/or (c) advancing our understanding of the neurobehavioral developmental mechanisms and trajectories of psychopathology that begin in childhood and adolescence. 

Letter of Intent : 5/22/2018

Full Application : 6/22/2018

National Center of Excellence for Tobacco-Free Recovery (Short Title: National Center – TFR)

The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Mental Health Services (CMHS) is accepting applications for fiscal year (FY) 2018 National Center of Excellence for Tobacco-Free Recovery (Short Title: National Center – TFR). The purpose of this program is to establish a national center with specialized subject matter expertise to provide training and technical assistance to states, local governments, tribal communities, behavioral health organizations, primary care providers, clinicians, peers, families, and other stakeholders to help reduce tobacco use among persons with behavioral health disorders, with an emphasis on individuals with serious mental illness (SMI) and co-occurring disorders (COD). The expectation is that the National Center – TFR will build upon and expand SAMHSA’ efforts to increase awareness, disseminate current research, educate behavioral health care providers, and create results-oriented collaborations among stakeholder organizations in an effort to reduce tobacco use among individuals with behavioral health disorders.

Application Due : June 1, 2018

Notice of Intent to Publish a Funding Opportunity Announcement for the Reissue of PA-18-568 International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional)

The National Institute on Drug Abuse (NIDA) intends to reissue PA-18-568, International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional) to solicit applications to encourage collaborative research applications on drug abuse and addiction. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.

Estimated Application Due DateJun 05, 2018 

Notice of Intent to Publish a Funding Opportunity Announcement for National Research Mentoring Network Coordinating Center (U24 - Clinical Trial Not Allowed)

The Office of Strategic Coordination (Common Fund) intends to publish three funding opportunity announcements (FOAs) to solicit applications for Phase II of the National Research Mentoring Network (NRMN), a component of the Enhancing the Diversity of the NIH-Funded Workforce Program.  This program, known as the Diversity Program Consortium (DPC), consists of three integrated initiatives: Building Infrastructure Leading to Diversity (BUILD), the National Research Mentoring Network (NRMN) and the Center for Evaluation and Coordination (CEC).   Continued Common Fund support for the DPC will provide the time and resources needed to (1) gather additional data to test site-specific and consortium-wide interventions; (2) transition into sustainable models for enhancing diversity in biomedical research fields; and (3) disseminate effective strategies to a broad range of institutions to have a lasting national impact.

Estimated Application Due DateJun 08, 2018 

Data Standards for Clinical Research and Drug Development (U24)

The FDA Center for Drug Evaluation and Research is encouraging applications for projects to expedite development of data standards and terminologies to support human drug development and evaluation. The primary objective is to support research and the development of non-proprietary, consensus-based, national data standards for use in clinical studies of human drugs and biologics. Projects may focus on solutions to general data standards development and implementation challenges or on specific clinical concepts, domains, or therapeutic areas where standardization is needed.

Application Due : May 15, 2018

Genomic Centers for Infectious Diseases (U19 Clinical Trial Not Allowed)

The purpose of this initiative is to support Genomic Centers for Infectious Diseases (GCID) to promote broad use and expand the application of genomics technologies and computational analysis to understand infectious diseases, with an emphasis on pathogens, their interaction with the host and microbiome, and to aid in the development of novel genomics-based tools to diagnose, prevent and treat infectious diseases. The GCID will support innovative technology development in all aspects of genomics, including the use of synthetic and genome editing technologies as well as functional genomics to address basic, translational, and clinically relevant questions in host-pathogen interactions. The knowledge generated, including research data, analytical software tools, computational models, experimental protocols, and reagents, is expected to be widely disseminated to the scientific community through publicly accessible databases and reagent repositories.

Application Due : Jun 22, 2018

Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Development (U19 Clinical Trial Not Allowed)

The purpose of this funding opportunity announcement (FOA) is to solicit applications for the Sexually Transmitted Infections Cooperative Research Centers (STI CRC) program. This STI CRC program will facilitate multidisciplinary, synergistic collaborations to support the development of vaccines to control and prevent sexually transmitted infections (STIs) caused by the following pathogens, which have limited candidates in the product development pipeline: Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum. In addition, the FOA will support the development of prophylactic vaccines for herpes simplex virus (HSV).

Application Due : Jun 20, 2018

Natural Product, Multi-Site, Clinical Trial, Data Coordinating Center (Collaborative U24 - Clinical Trial Required)

This Funding Opportunity Announcement (FOA) , utilizing the U24 grant funding mechanism, encourages applications for a collaborating Data Coordinating Center (DCC) application that accompanies investigator-initiated, multi-site clinical trials (Phase III and beyond) applications submitted under PAR-18-124 (https://grants.nih.gov/grants/guide/pa-files/PAR-18-124.html). The DCC application must be specific to the collaborating Clinical Coordinating Center (CCC) application. The objective of the DCC application Is lo propose a, comprehensive plan that provides overall project coordination. and administrative, data management and biostatistical support for the proposed clinical trial. Both a DCC application and a corresponding CCC application need to be submitted simultaneously for consideration by NCCIH. Trials for which this FOA applies must be relevant to the research mission of the NCCIH and considered a high priority by the Center.

Application Due : Nov 04, 2019

Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites applications for centers to support transdisciplinary teams of clinical and mental health services researchers, behavioral scientists, social scientists, health information and communications technologists, health systems engineers, decision scientists, and mental health stakeholders (e.g., service users, family members, clinicians, payers) to engage in high-impact studies that will significantly advance clinical practice and generate knowledge that will fuel transformation of mental health care in the United States. Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers will support the rapid development, testing, and refinement of novel and integrative approaches for (1) optimizing the effectiveness of therapeutic or preventive interventions for mental disorders within well-defined target populations; (2) organizing and delivering optimized mental health services within real world treatment settings; and (3) continuously improving the quality, impact, and durability of optimized interventions and service delivery within diverse care systems.

Application Due : May 18, 2020

 

Center for Research on Hispanic Children and Families

The Office of Planning, Research and Evaluation (OPRE) within the Administration for Children and Families (ACF) is considering soliciting applications for a Center for Research on Hispanic Children and Families, to lead and support investigation of the needs of Hispanic populations served by ACF and promising approaches to promote social and economic well-being among low-income Hispanic families. This research center (hereafter referred to as "Center") would ideally bring together a diverse, interdisciplinary team of academic and organizational partners to provide leadership in culturally competent research that can inform policies concerning low-income Hispanic families and to foster significant scholarship regarding the needs and experiences of the diverse Hispanic populations throughout the nation.

Application Due : Jun 15, 2018

 

 

National Research Mentoring Network (NRMN) Resource Center (U24 - Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from qualified institutions for the NIH National Research Mentoring Network (NRMN) Resource Center. The NRMN is a nationwide consortium intended to enhance the training and career development of biomedical researchers from diverse backgrounds, through enhanced networking and mentorship experiences. One grant will be awarded for the development and management of a NRMN Resource Center, which will provide a web-based mentoring tool to facilitate real-time mentor/mentee engagement and networking. The awardee will also oversee the management of the NRMN website, report on outputs from NRMN components, and serve as a repository for publicly available mentoring resources and tools.

Application Due : June 11,2018

National Research Mentoring Network (NRMN) Coordination Center (U24 - Clinical Trial Not Allowed)

The National Research Mentoring Network (NRMN) is a nationwide consortium developed to enhance the training and career development of individuals from diverse backgrounds who are pursuing biomedical research careers by providing networking and mentorship experiences. The NRMN Coordination Center will provide infrastructure and expertise that supports the collection, secure storage, and reporting of data generated by the individual NRMN component projects. Building upon the instruments and processes developed to assess the impact of NRMN activities in the previous Diversity Program Consortium (DPC) funding period, the NRMN Coordination Center will coordinate the early stages of collection of data in an ongoing way, and provide feedback to the consortium to maximize the research benefit of the various NRMN activities. The NRMN Coordination Center will also be responsible for promoting synergistic interactions with the DPC Center for Evaluation and Coordination (CEC) for the long-term collection and storage of data.

Application Due : June 11,2018

National Research Mentoring Network: The Science of Mentoring, Networking, and Navigating Career Transition Points (U01 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the second phase of the NIH National Research Mentoring Network (NRMN) efforts. The NRMN is a nationwide consortium that was designed to enhance mentoring and career development of individuals from groups underrepresented in the biomedical research workforce. This new cycle of NRMN will expand the scientific scope of the program to encourage grants with varied approaches aimed at the science of mentorship, networking, and navigating critical career transition points. The NRMN will be a set of cooperative agreements in which the Program Directors/Principal Investigators (PDs/PIs) will work through a NRMN Coordination Center and the NRMN Resource Center to disseminate effective resources. The NRMN research is expected to align with the hallmarks of success that have been defined by the Diversity Program Consortium and the Center for Evaluation and Coordination (CEC).

Application Due : June 11,2018

 

 

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required

The purpose of this Funding Opportunity Announcement (FOA) is to solicit UG3/UH3 phased cooperative agreement research applications to plan and implement behavioral and social intervention clinical trials. Studies appropriate for this announcement include traditional clinical trials meant to develop and test behavior change interventions meant to prevent or treat dental, oral, or craniofacial conditions, as well as interventions that are used as tools to understand mechanisms of behavior change. Awards made under this FOA will initially support a milestone-driven planning phase (UG3) for up to 2 years, with possible transition to a clinical trial implementation phase of up to five years (UH3). Only UG3 projects that have met the scientific milestones and feasibility requirements may transition to the UH3 phase.

Application Due : Jan 07, 2021

 Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54s). The mission of the CounterACT program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents, toxic industrial chemicals, pharmaceutical-based agents, and pesticides. The scope of the research includes target and candidate identification and characterization, through candidate optimization and demonstration of in vivo efficacy consistent with the product's intended use in humans.

Application Due : Sep 09, 2020

NIAMS Skin Biology and Diseases Resource-based Centers (P30)

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for skin biology and diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on skin biology and diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research within the NIAMS mission.

Application Due : Jun 11, 2018

 

 

 

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

Application Due : Jan 07, 2021

Notice of Intent to Publish a Funding Opportunity Announcement for A Practice-Based Research Network to Transform Mental Health Care: Science, Service Delivery & Sustainability (U19 Clinical Trial Required)

The NIMH intends to publish a Funding Opportunity Announcement (FOA) Cooperative Agreement (U19) to solicit applications for a practice-based research network to transform mental health care.   The planned FOA will support a practice-based research network in the United States to transform the development, delivery, and sustainability of evidence-based mental health practices and services. Through a research consortium embedded within large and integrated healthcare delivery systems, this Network would result in a continuously learning healthcare system as defined by the Institute of Medicine, to create “a continuous cycle or feedback loop in which scientific evidence informs clinical practice while data gathered from clinical practice and administrative sources inform scientific investigation.

Application Due : June 01, 2018

Training Modules to Enhance the Rigor and Reproducibility of Biomedical Research (R25 Clinical Trial Not Allowed)

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs and foster a better understanding of biomedical, behavioral and clinical research and its implications.

Application Due : June 29, 2018

Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed)

The Shared Instrumentation for Animal Research (SIFAR) Grant Program encourages applications from groups of NIH-funded investigators to purchase or upgrade scientific instruments necessary to carry out animal experiments in all areas of biomedical research supported by the NIH. Applicants may request clusters of commercially available instruments configured as specialized integrated systems or as series of instruments to support a thematic well-defined area of research using animals or related materials. Priority will be given to uniquely configured systems to support innovative and potentially transformative investigations. This FOA supports requests for state-of-the art commercially available technologies needed for NIH-funded research using any vertebrate and invertebrate animal species. This funding opportunity announcement (FOA) does not support requests for single instruments. At least one item of the requested instrumentation must cost at least $50,000, after all applicable discounts. No instrument in a cluster can cost less than $20,000, after all applicable discounts. There is no maximum price requirement; however, the maximum award is $750,000.

Application Due : May 31, 2018

Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)

The Shared Instrument Grant (SIG) Program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems. The minimum award is $50,000. There is no maximum price requirement; however, the maximum award is $600,000. Types of instruments supported include, but are not limited to: X-ray diffractometers, mass and nuclear magnetic resonance (NMR) spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, cell sorters, and biomedical imagers.

Application Due : May 31, 2018

High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)

The High-End Instrumentation (HEI) Grant Program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $600,001. The maximum award is $2,000,000. Types of instruments supported include, but are not limited to: X-ray diffraction systems, nuclear magnetic resonance (NMR) and mass spectrometers, DNA and protein sequencers, biosensors, electron and confocal microscopes, cell-sorters, and biomedical imagers.

Application Due : May 31, 2018

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding specific types of research grants (activity codes listed above) that funds are available for administrative supplements to improve the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project. Administrative supplements must support work within the scope of the original project.

Application Due : Sep 07, 2021

 

NEI Translational Research Program (TRP) to Develop Novel Therapies and Devices for the Treatment of Visual System Disorders (R24)

In the context of this program, an expert assembles a multi-disciplinary research team that uses an integrative approach to develop rapid and efficient translation of innovative laboratory research findings into therapies, devices or other resources for use by clinicians to treat visual system diseases or disorders. It involves collaborative teams of scientists and clinicians with expertise in multiple disciplines, operating according to a clear leadership plan. Such a collaborative approach is particularly appropriate for research focused on pathways that will likely be targeted by biological intervention, such as gene therapy, cell-based therapy, pharmacological approaches, and the development and use of medical devices. 

Application Due : March 27, 2019

Obesity Policy Evaluation Research (R01)

This Funding Opportunity Announcement (FOA) encourages applications that propose to evaluate policies or large scale programs that are expected to influence obesity related behaviors (e.g., dietary intake, physical activity, or sedentary behavior) and/or weight outcomes have the potential to prevent or reduce rates of obesity. 

Application Due : June 5, 2018

 

BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01) (Clinical Trials Not Allowed)

This funding opportunity announcement (FOA), in support of the NIH Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, aims to support full development of entirely new or next generation noninvasive human brain imaging tools and methods that will lead to transformative advances in our understanding of the human brain. The FOA seeks innovative applications that are ready for full-scale development of breakthrough technologies with the intention of delivering working tools within the timeframe of the BRAIN Initiative (BRAIN 2025: A Scientific Vision, http://braininitiative.nih.gov/). This FOA represents the second stage of the tool/technology development effort that started with RFA-MH-14-217 and RFA-MH-15-200

Application Due : Dec 11, 2018

Notice of Intent to Publish a Funding Opportunity Announcement for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)

​The National Institute of Neurological Disorders and Stroke (NINDS), intends to re-issue a Program Announcement with Special Review Considerations (PAR) to solicit applications for "Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54)". The goal of this initiative is to provide support for translational research to develop therapeutics for reducing mortality and morbidity caused by acute exposures to chemical threat agents. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. The scope of the research includes target and candidate identification and characterization, through candidate optimization and demonstration of in vivo efficacy consistent with the product's intended use in humans. 

Application Due : Sep 01, 2018

 Department of Defense

White Paper: This BAA is open and effective through 1 March 2021 at 5:00 pm Local Time, WrightPatterson Air Force Base. White papers may be submitted at any time during this period.

Proposal: To be provided in response to the Requests for Proposals sent to offerors that submit White Papers considered to meet the needs of the Air Force.

The mission of the OCRP is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer. Although not required, investigators are encouraged to address one of the FY17 Areas of Encouragement in their applications.

Full Application: TBD

Breast Cancer Research Program Anticipated Funding Opportunities for Fiscal Year 2017
Due to the current Continuing Resolution, the Fiscal Year 2017 (FY17) Defense Appropriations bill has not been passed. Although funds have not been appropriated for the Department of Defense Breast Cancer Research Program (BCRP), the BCRP is providing the information in this pre-announcement to allow investigators time to plan and develop ideas for submission to the anticipated FY17 funding opportunities.
Full Application: TBD

As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency (DHA) Research and Development Directorate (J9) manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).
Pre-Application: varies
Full Application:varies

Cancer Prevention and Research Institute of Texas

American Association for Cancer Research 

NASA

2017 NASA HERO NRA

This National Aeronautics and Space Administration (NASA) Research Announcement (NRA), entitled Human Exploration Research Opportunities (HERO)–2017, solicits research in support of NASA’s Human Research Program (HRP). The HRP contains six Elements: Space Radiation, Human Health and Countermeasures, Exploration Medical Capability, Behavioral Health and Performance, Space Human Factors and Habitability, and International Space Station Medical Project. Fourteen disciplines or areas support the Program: Behavioral Health and Performance, Bone, Cardiovascular, Extravehicular Activity, Immunology, Medical Capabilities, Muscle, Nutrition, Pharmacology, Radiation, Sensorimotor, Advanced Food Technology, Advanced Environmental Health, and Space Human Factors Engineering. Awards generally range from under $100K per year for focused, limited efforts (e.g., data analysis) to $1M per year for extensive activities (e.g., development of scientific hardware). The funds available for awards in each program element offered in this solicitation range from less than one to several million dollars, which allows NASA to select a few to numerous proposals depending on the program objectives and the submission of proposals of merit. This solicitation may result in grant, cooperative agreement, and contract awards. 

Deadlines vary. See http://nspires.nasaprs.com/ for more information.

Patient-Centered Outcomes Research Institute (PCORI)